Rate this Article: A Randomized, Open-Label, Active-Controlled, Phase 3 Clinical Trial of FDC Erdosteine 300 mg and Acebrophylline 100 mg Tablet versus FDC Acebrophylline 100 mg and Acetylcysteine 600 mg Tablet in Treatment of Chronic Bronchitis in Participants with Chronic Obstructive Pulmonary Disease

Rating (1-10):

1

Comments (SR251202172147):

Please enter 100–200 characters. 0/200 characters

Full Name: Email Address (Important: You will receive Rating Verification Link on this Email Address):

Leave this field empty

Back to Article